Temasek Leads Series C in ASLAN Pharmaceuticals
Posted on 12/07/2015
Singapore-based ASLAN Pharmaceuticals Pte. Ltd. raised US$ 34 million in a Series C round. The round was led by Accuron Technologies, a sovereign wealth enterprise of Singapore’s Temasek Holdings. New investors in the Series C round include Tianda Pharmaceuticals and Haitong International. Existing investors that participated in the round are Morningside Group, Singapore-based BioVeda Capital, […]
